Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Haemonetics's Business Segments
Haemonetics's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 ((Jun 27 2026))
Reportable Segments
3
Largest Segment
Apheresis
Total Revenue
$ 339
Regions Reported
4
Revenue Share by Reportable Segment - Q1 ((Jun 27 2026))
- Apheresis56.4%
- MedSurg43.6%
- Other Country or Region0.9%
Revenue by Reportable Segment - Q1 ((Jun 27 2026))
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Apheresis | $ 191 | 56.4% |
| MedSurg | $ 148 | 43.6% |
| Other Country or Region | $ 3 | 0.9% |
Revenue Share by Region - Q1 ((Jun 27 2026))
- United States76%
- Europe13.4%
- Asia5.9%
- Japan3.8%
Revenue by Geographic Region - Q1 ((Jun 27 2026))
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| United States | $ 258 | 76% |
| Europe | $ 46 | 13.4% |
| Asia | $ 20 | 5.9% |
Annual Results
Revenue Share by Reportable Segment - FY2026
- Hospital44.1%
- Plasma39.3%
- Blood Center16.6%
Revenue by Reportable Segment - FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Hospital | $ 588 | 44.1% |
| Plasma | $ 524 | 39.3% |
| Blood Center | $ 221 | 16.6% |
Revenue Share by Region - FY2026
- Europe13.9%
- Asia6.5%
Revenue by Geographic Region - FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Europe | $ 185 | 13.9% |
| Asia | $ 87 | 6.5% |
Revenue by Product & Service Category - FY2026
- Plasma Products and Services39.3%
- Hospital Products and Services17.5%
- Blood Center Products and Services16.6%
Revenue by Product & Service Category - FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Plasma Products and Services | $ 524 | 39.3% |
| Hospital Products and Services | $ 234 | 17.5% |
| Blood Center Products and Services | $ 221 | 16.6% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Haemonetics
Haemonetics Corporation is a U.S. based company that specializes in providing innovative blood management solutions to healthcare facilities and blood donation centers across the globe. The company was founded in 1971 and is headquartered in Braintree, Massachusetts. Haemonetics Corporation has a market cap of roughly $4.4 billion and trades on the New York Stock Exchange under the ticker symbol HAE.
The company has a wide range of products and services including blood collection and processing equipment, blood component extraction and storage systems, and software platforms for blood management. Haemonetics Corporation's major products include:
1. Blood Collection Devices and Systems - Haemonetics Corporation produces a variety of different products designed to collect blood safely and efficiently. These devices include manual and automated collection instruments, needles and tubing, and blood bags.
2. Blood Component Separation and Storage Systems - The company produces systems that separate blood into its various components such as red blood cells, plasma, and platelets. These components can then be stored separately and used for various medical procedures as needed.
3. Blood Management Software - In order to assist healthcare facilities with managing their blood inventory and ensuring patient safety, Haemonetics Corporation offers a range of software applications. These applications allow healthcare professionals to track blood usage, monitor inventory levels, and analyze patient transfusion trends.
Haemonetics Corporation serves a diverse range of clients, including hospitals, blood banks, and surgery centers. The company's products and services are used in a variety of medical procedures, including surgeries, transfusions, and emergency care.
The company has a global presence, with operations in over 50 countries. Haemonetics Corporation employs approximately 3,200 people worldwide and has manufacturing facilities in the U.S., Mexico, and Switzerland.
In recent years, Haemonetics Corporation has made significant investments in research and development, with a focus on developing new products that enhance blood management practices and improve patient outcomes. The company has also been actively acquiring other firms in the industry, further expanding its product portfolio and market share.
Overall, Haemonetics Corporation is a highly reputable and innovative company that is dedicated to providing the highest quality blood management solutions to healthcare facilities worldwide.
The company has a wide range of products and services including blood collection and processing equipment, blood component extraction and storage systems, and software platforms for blood management. Haemonetics Corporation's major products include:
1. Blood Collection Devices and Systems - Haemonetics Corporation produces a variety of different products designed to collect blood safely and efficiently. These devices include manual and automated collection instruments, needles and tubing, and blood bags.
2. Blood Component Separation and Storage Systems - The company produces systems that separate blood into its various components such as red blood cells, plasma, and platelets. These components can then be stored separately and used for various medical procedures as needed.
3. Blood Management Software - In order to assist healthcare facilities with managing their blood inventory and ensuring patient safety, Haemonetics Corporation offers a range of software applications. These applications allow healthcare professionals to track blood usage, monitor inventory levels, and analyze patient transfusion trends.
Haemonetics Corporation serves a diverse range of clients, including hospitals, blood banks, and surgery centers. The company's products and services are used in a variety of medical procedures, including surgeries, transfusions, and emergency care.
The company has a global presence, with operations in over 50 countries. Haemonetics Corporation employs approximately 3,200 people worldwide and has manufacturing facilities in the U.S., Mexico, and Switzerland.
In recent years, Haemonetics Corporation has made significant investments in research and development, with a focus on developing new products that enhance blood management practices and improve patient outcomes. The company has also been actively acquiring other firms in the industry, further expanding its product portfolio and market share.
Overall, Haemonetics Corporation is a highly reputable and innovative company that is dedicated to providing the highest quality blood management solutions to healthcare facilities worldwide.
Haemonetics Corporation is a prominent global entity specializing in blood management solutions, catering to hospitals, blood banks, and plasma collection centers. The organization has divided its offerings into various segments, products, and services aimed at enhancing patient outcomes and optimizing operational efficiencies within the healthcare sector. Here’s an extensive breakdown of Haemonetics’ segments, products, and services:
Segments:
1. Blood Center:
- This segment is dedicated to offering innovative solutions for blood banks and plasma collection centers around the globe. Haemonetics focuses on advanced technologies for blood collection and processing that ensure the quality, safety, and efficacy of blood components. Solutions in this segment also aim to streamline operations and improve yield from donations, thereby increasing the overall efficiency of blood centers.
2. Hospital:
- The hospital segment provides comprehensive blood management systems designed to oversee and improve the entire blood supply chain within healthcare facilities. This can include tools for blood ordering and tracking, as well as efficient inventory management systems. These solutions help minimize blood waste, ensure timely availability for patients, and ultimately improve clinical outcomes.
Products:
1. Cell Saver Elite+:
- The Cell Saver Elite+ is a state-of-the-art cell salvage system that allows for efficient collection of a patient’s own blood during surgical procedures. It features advanced volume reduction technologies and patient safety mechanisms, making it an essential tool in surgeries that have a high risk of blood loss, thereby facilitating a more effective recovery and reducing the need for donor blood.
2. TEG 6s:
- The TEG 6s (Thromboelastography) analyzer is a cutting-edge diagnostic tool used by healthcare professionals to monitor patients hemostatic (clotting) functions. This instrument allows for the real-time assessment of a patients responsiveness to various anticoagulant and antiplatelet therapies, enabling tailored treatment plans and better management of bleeding risks during surgery or critical care.
3. Plasma Collection:
- Haemonetics provides a comprehensive suite of technologies and devices tailored for plasma collection centers. These solutions include user-friendly interfaces and equipment designed to enhance the donor experience while ensuring optimal plasma collection processes. The emphasis is on improving efficiency, safety, and quality in plasma collection.
4. Blood Collection:
- The companys blood collection solutions encompass a range of products such as automated blood collection systems, sterile blood bags, and specialized needles. These products are engineered to enhance the efficacy and safety of the blood donation process, reduce contamination risk, and improve the overall donor experience.
Services:
1. Consulting Services:
- Haemonetics offers expert consulting services that assist hospitals and blood centers in refining their blood management practices. This could include analysis of existing workflows, strategies for improving donation rates, and implementation of best practices in blood usage, ultimately aiming to enhance operational efficiencies and patient care outcomes.
2. Technical Services:
- The technical services offered by Haemonetics ensure that their products and equipment remain functional and reliable. This includes on-site support, maintenance services, and troubleshooting, which are vital for minimizing downtime and ensuring that blood management systems operate at peak performance.
3. Education and Training:
- The education and training services provided by Haemonetics are designed to empower healthcare personnel with the knowledge and skills necessary to leverage the company’s products effectively. By offering training sessions, workshops, and educational materials, Haemonetics supports hospitals and blood banks in maximizing the benefits of their blood management solutions, thereby fostering a culture of continuous improvement and excellence in patient care.
Conclusion:
Overall, Haemonetics Corporation’s diverse range of segments, products, and services is meticulously designed to enhance the quality and efficiency of blood management solutions. By focusing on innovation and the specific needs of hospitals, blood banks, and plasma collection centers, Haemonetics continues to play a pivotal role in advancing patient outcomes and optimizing healthcare operational practices globally.
Segments:
1. Blood Center:
- This segment is dedicated to offering innovative solutions for blood banks and plasma collection centers around the globe. Haemonetics focuses on advanced technologies for blood collection and processing that ensure the quality, safety, and efficacy of blood components. Solutions in this segment also aim to streamline operations and improve yield from donations, thereby increasing the overall efficiency of blood centers.
2. Hospital:
- The hospital segment provides comprehensive blood management systems designed to oversee and improve the entire blood supply chain within healthcare facilities. This can include tools for blood ordering and tracking, as well as efficient inventory management systems. These solutions help minimize blood waste, ensure timely availability for patients, and ultimately improve clinical outcomes.
Products:
1. Cell Saver Elite+:
- The Cell Saver Elite+ is a state-of-the-art cell salvage system that allows for efficient collection of a patient’s own blood during surgical procedures. It features advanced volume reduction technologies and patient safety mechanisms, making it an essential tool in surgeries that have a high risk of blood loss, thereby facilitating a more effective recovery and reducing the need for donor blood.
2. TEG 6s:
- The TEG 6s (Thromboelastography) analyzer is a cutting-edge diagnostic tool used by healthcare professionals to monitor patients hemostatic (clotting) functions. This instrument allows for the real-time assessment of a patients responsiveness to various anticoagulant and antiplatelet therapies, enabling tailored treatment plans and better management of bleeding risks during surgery or critical care.
3. Plasma Collection:
- Haemonetics provides a comprehensive suite of technologies and devices tailored for plasma collection centers. These solutions include user-friendly interfaces and equipment designed to enhance the donor experience while ensuring optimal plasma collection processes. The emphasis is on improving efficiency, safety, and quality in plasma collection.
4. Blood Collection:
- The companys blood collection solutions encompass a range of products such as automated blood collection systems, sterile blood bags, and specialized needles. These products are engineered to enhance the efficacy and safety of the blood donation process, reduce contamination risk, and improve the overall donor experience.
Services:
1. Consulting Services:
- Haemonetics offers expert consulting services that assist hospitals and blood centers in refining their blood management practices. This could include analysis of existing workflows, strategies for improving donation rates, and implementation of best practices in blood usage, ultimately aiming to enhance operational efficiencies and patient care outcomes.
2. Technical Services:
- The technical services offered by Haemonetics ensure that their products and equipment remain functional and reliable. This includes on-site support, maintenance services, and troubleshooting, which are vital for minimizing downtime and ensuring that blood management systems operate at peak performance.
3. Education and Training:
- The education and training services provided by Haemonetics are designed to empower healthcare personnel with the knowledge and skills necessary to leverage the company’s products effectively. By offering training sessions, workshops, and educational materials, Haemonetics supports hospitals and blood banks in maximizing the benefits of their blood management solutions, thereby fostering a culture of continuous improvement and excellence in patient care.
Conclusion:
Overall, Haemonetics Corporation’s diverse range of segments, products, and services is meticulously designed to enhance the quality and efficiency of blood management solutions. By focusing on innovation and the specific needs of hospitals, blood banks, and plasma collection centers, Haemonetics continues to play a pivotal role in advancing patient outcomes and optimizing healthcare operational practices globally.